India Bispecific Antibodies Market Size & Outlook, 2025-2031
India Bispecific Antibodies Market Size
According to Straits Research analysis, the India Bispecific Antibodies Market was valued at USD 230.02 Million in 2024 and is projected to reach USD 672.78 Million by 2031, expanding at a CAGR of 17.4% during the forecast period. The main drivers for this growth are applications in healthcare and pharmaceutical industries where these antibodies are used in diagnostics and as a novel therapeutic strategy against diseases like cancer. Key drivers include the advancing biotechnological field, burgeoning cancer cases and robust demand for efficacious therapies. Emerging trends in the market include the adoption of green biotechnology and extensive research in genetic engineering that propels sustainable development. Combining the potential for technological advancements and strong export possibilities, India is sturdily positioning itself as a robust player in the global bispecific antibodies market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Bispecific Antibodies Market Highlights
- Bi-specific T-cell engager held the leading position among Type segments in 2024, based on market size.
- Bi-specific T-cell engager is projected to post the fastest growth rate, sustaining its position as the most attractive Type segment during the forecast horizon.
- As of 2024, India held 4.17% of the global bispecific antibodies market size.
- By 2031, United States is anticipated to capture the largest share of the global bispecific antibodies market.
- In Asia Pacific, China is expected to lead the regional bispecific antibodies market size by 2031.
- India will remain the fastest-growing market in Asia Pacific, reaching USD 454.85 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 230.02 Million |
| Market Size In 2031 | USD 672.78 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 17.4% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
India Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
India Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
